“As the first biosimilar to Simponi (golimumab) to gain approval in the European market, we are committed to expanding access ...
Poolbeg Pharma has announced that the European Patent Office has granted its European Immunomodulator II patent application ...
Protara Therapeutics has announced encouraging interim results from its ongoing phase 2 STARBORN-1 trial evaluating TARA-002 ...
The European Commission has approved Libtayo (cemiplimab) as the first and only immunotherapy for adult patients with ...
Cellbyte, a Munich-based AI-native platform helping pharmaceutical companies accelerate drug launches, has raised $2.75 ...
GSK and the Fleming Initiative have announced six new research programmes to combat antimicrobial resistance (AMR), backed by ...
Scottish Brain Sciences (SBS) has opened a new clinical research centre at ONE BioHub in Aberdeen, marking a significant step forward in early Alzheimer’s research and trial accessibility across ...
Biogen has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback